
Insights from 2024 EHA Annual Meeting
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
EHA 2024 Insights: The Impact of TP53 Mutation Burden on Risk & Treatment Decision in Newly Diagnosed CLL
By
Insights from 2024 EHA Annual Meeting
FEATURING
Maher Salamoon
By
Insights from 2024 EHA Annual Meeting
FEATURING
Maher Salamoon
209 views
June 28, 2024
Chapters
Epidemiology & Significance of TP53 Mutation in CLL
00:00
TP53 Aberration Impact on Treatment Choices
01:52
Strategies for Managing Low Burden TP53 Mutations
06:40
Study Results: CLL Treatment & TP53 Mutation Burden
09:20
Comments 0
Login to view comments.
Click here to Login
Videos